Directly protects endothelial walls using profound nitric oxide (NO) generation
Criner, MD 1 and the COPDGene Investigators Author Affiliations | Correspondence | Abstract | Citation | Keywords | PDF Author Affiliations Department of Pulmonary and Critical Care Medicine, Temple University Hospital, Philadelphia, Pennsylvania Department of Radiology, Temple University Hospital, Philadelphia, Pennsylvania Temple Clinical Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania *Co-first Authors Address correspondence to: Cynthia Kim, MD Temple Lung Center 7th Floor Parkinson Pavilion 3401 North Broad Street Philadelphia, PA 19140 Phone: 267-858-2735 Email: [email protected] Abstract Background: Gastroesophageal reflux disease (GERD) is associated with frequent chronic obstructive pulmonary disease (COPD) exacerbations
BPC-157 Quality & Traceability Every AXION compound is subject to analytical verification before release
The fact that it does not means that BPC-157 works via signaling cascades , it triggers an avalanche, which you dont need to feed with a large quantity of the substance
